Research and analysis

COVID-19: laboratory evaluations of serological assays

PHE has undertaken a number of rapid evaluations of commercial serological assays for their suitability for detecting the production of COVID-19 antibodies.

Documents

Supporting information for the PHE commercial serology assay evaluations

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Evaluation of the Beckman Coulter Access Anti-SARS-CoV-2 IgG assay for the detection of anti-SARS-CoV-2 antibodies

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Evaluation of Siemens Atellica-IM Total (COV2T) SARS-CoV-2 serology assay for the detection of anti-SARS-CoV-2 total antibodies

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Evaluation of the Ortho Clinical Diagnostics Vitros Immunodiagnostic Products Anti-SARS-CoV-2 Totalserology assay for the detection of anti-SARS-CoV-2 antibodies

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Evaluation of DiaSorin LIAISON SARS-CoV-2 S1/S2 IgG serology assay for the detection of anti-SARS-CoV-2 antibodies

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Evaluation of the Euroimmun Anti-SARS-CoV-2 ELISA (IgG) serology assay for the detection of anti-SARS-CoV-2 antibodies

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Evaluation of Abbott SARS-CoV-2 IgG for the detection of anti-SARS-CoV-2 antibodies

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Evaluation of Roche Elecsys Anti-SARS-CoV-2 serology assay for the detection of anti-SARS-CoV-2 antibodies

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Evaluation of the Ortho Clinical Diagnostics Vitros Immunodiagnostic Products Anti-SARS-CoV-2 IgG serology assay for the detection of anti-SARS-CoV-2 antibodies

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Please refer to the position statement and conflict of interest statement regarding these evaluations.

Published 19 May 2020
Last updated 25 August 2020 + show all updates
  1. Added Beckman Coulter Access Anti-SARS-CoV-2 IgG assay and supporting information for the PHE commercial serology assay evaluations.

  2. Added 'Evaluation of Siemens Atellica-IM Total (COV2T) SARS-CoV-2 serology assay for the detection of anti-SARS-CoV-2 total antibodies' and 'Evaluation of the Ortho Clinical Diagnostics Vitros Immunodiagnostic Products Anti-SARS-CoV-2 Totalserology assay for the detection of anti-SARS-CoV-2 antibodies'.

  3. Added 'Evaluation of DiaSorin LIAISON SARS-CoV-2 S1/S2 IgG serology assay for the detection of anti-SARS-CoV-2 antibodies' and 'Evaluation of the Euroimmun Anti-SARS-CoV-2 ELISA (IgG) serology assay for the detection of anti-SARS-CoV-2 antibodies'.

  4. Updated Evaluation of Roche Elecsys Anti-SARS-CoV-2 serology assay for the detection of anti-SARS-CoV-2 antibodies.

  5. Updated Evaluation of Abbott SARS-CoV-2 IgG for the detection of anti-SARS-CoV-2 antibodies.

  6. Added Evaluation of the Ortho Clinical Diagnostics Vitros Immunodiagnostic document.

  7. Added updated Abbott and Roche evaluation reports.

  8. Updated reports.

  9. First published.